Aesthetic injectables manufacturer and regional hyaluronic acid leader
Rennova manufactures and distributes facial and body aesthetic products across 23+ countries, anchored by hyaluronic acid and biostimulator formulations developed in Austria and Israel. The company's tech stack is heavily weighted toward content creation and sales enablement (Adobe Creative Suite, Meta/YouTube, Salesforce) with SAP and SQL Server for operations—a pattern typical of a brand-driven distributor scaling through medical professional networks. Active hiring is concentrated in marketing (21 open roles) and sales (8), reflecting a go-to-market expansion phase rather than product R&D.
Rennova is a publicly traded pharmaceutical manufacturer based in Goiânia, Brazil, specializing in aesthetic injectables for facial and body applications. Founded in 2008, the company has positioned itself as the largest hyaluronic acid importer in Latin America and maintains a regional footprint across 23+ countries. Products are sold to physicians and aesthetic professionals through a distributor-enabled channel. The organization operates on SAP Business One, uses Salesforce for sales and marketing cloud operations, and coordinates product launches, influencer partnerships, and trade marketing programs. Current pain points center on distributor profitability, inventory accuracy, SAP-to-WMS integration, and expanding the product portfolio.
Rennova manufactures hyaluronic acid and biostimulator injectables for facial and body aesthetics. The company sources and formulates these products using purification technologies developed in Austria and Israel.
Rennova is headquartered in Goiânia, Goiás, Brazil. The company is a public company with 501–1,000 employees.
Other companies in the same industry, closest in size